Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, notes the announcement made by EKF Diagnostics Holdings PLC (“EKF”) this morning (RNS 3845P), declaring the distribution of its Verici Dx Investment Shares to Relevant EKF Shareholders via a distribution in specie.
These shares comprise of 9,098,611 ordinary shares in Verici Dx of £0.001 each and are subject to a Lock-up Period of 365 days from transfer.
Full details can be seen in the EKF announcement here:
Capitalised terms in this announcement carry the same definitions as in the EKF announcement.
OFFICE & LABORATORY ADDRESS:
393 Nichol Mill Lane, Suite 200
Franklin, TN 37067
REGISTERED OFFICE:
Avon House
19 Stanwell Road
Penarth
Cardiff, CF64 2EZ
CALL US AT:
Phone: +1 (833) 243-4552
Fax: +1 (629) 235-4545
